✦ LIBER ✦

Detection and its clinical value of minimal residual diseases in acute promyelocytic leukemia

✍ Scribed by Guo-sheng Jiang; Tian-hua Tang; Ke-hong Bi; Yu-kun Zhang; Hai-quan Ren; Liang-yu Zhao; Gui-yue Guo; Xiu-lan Liu; Qing-hua Ren; Feng-qin Jiang; Chuan-fang Liu; Jun Peng; Zhi-gang Tian

Book ID: 107466649
Publisher: Chinese Anti-Cancer Association
Year: 2002
Tongue: English
Weight: 370 KB
Volume: 14
Category: Article
ISSN: 1000-9604
DOI: 10.1007/s11670-002-0063-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon may reduce minimal residual d

Interferon may reduce minimal residual disease of acute promyelocytic leukemia

✍ Egyed, M; Rumi, G; Boros, B; Páldi-Haris, P; Földi, J 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 310 KB

Detection of minimal residual disease in

Detection of minimal residual disease in acute myeloid leukemia

✍ Maria R. Baer 📂 Article 📅 2002 🏛 Current Science Inc. 🌐 English ⚖ 236 KB

Clinical significance of minimal residua

Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia

✍ Misato Kikuchi; Junji Tanaka; Takeshi Kondo; Satoshi Hashino; Masaharu Kasai; Mi 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 276 KB

Detection of minimal residual disease in

Detection of minimal residual disease in acute leukemia by flow cytometry

✍ Dario Campana; Elaine Coustan-Smith 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

Patients with acute leukemia in clinical remission may still have up to 10 10 residual malignant cells (the upper limit of detection by standard morphologic techniques). Sensitive techniques to detect minimal residual disease (MRD) may allow better estimates of the leukemia burden and help the selec

Early detection of minimal residual dise

Early detection of minimal residual disease by reverse transcriptase polymerase chain reaction predicts relapse in acute promyelocytic leukemia

✍ E. Koller; H. Karlic; O. Krieger; M. Mistrik; G. Michlmayr; H. Gadner; D. Lutz; 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 391 KB

Monitoring of minimal residual disease i

Monitoring of minimal residual disease in acute myeloid leukemia

✍ Wolfgang Kern; Claudia Haferlach; Torsten Haferlach; Susanne Schnittger 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 587 KB

## Abstract Two highly sensitive methods, multiparameter flow cytometry (MFC) and real‐time quantitative PCR (RQ‐PCR), are increasingly used to monitor minimal residual disease (MRD) and to guide risk‐adapted management in acute myeloid leukemia (AML). An independent prognostic impact has been demo